KELLY MITCHELL, M.D.
Ophthalmology Physician · LUBBOCK, TX
Individual Active NPI 1811988751
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 395 | 14,352 | $1,734,116 | $694,159 | $544,042 |
| 2023 | 375 | 18,739 | $2,343,014 | $977,806 | $771,249 |
| 2022 | 386 | 5,257 | $1,789,614 | $809,420 | $633,128 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 11,704 | $32 | $26 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 680 | $129 | $96 |
| 92134 | Imaging of retina | 641 | $40 | $30 |
| 67028 | Injection of drug into eye | 373 | $120 | $92 |
| 92250 | Photography of the retina | 279 | $37 | $28 |
| J7999 | Compounded drug, not otherwise classified | 110 | $98 | $77 |
| J0178 | Injection, aflibercept, 1 mg | 88 | $798 | $634 |
| 92014 | Established patient complete exam of visual system | 60 | $126 | $94 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 50 | $92 | $68 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 35 | $167 | $130 |
| J9035 | Injection, bevacizumab, 10 mg | 30 | $70 | $56 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | L1942 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1376530071
- NPI 1437347242
- NPI 1144259656
- NPI 1912698929
- NPI 1336998475
- NPI 1205931136
- NPI 1548527047
- NPI 1336231265
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.